MarketWatch Automation
The AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +1.05% inched 0.52% higher to $58.40 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +3.33% rising 0.23% to 15,188.39 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.76% rising 0.11% to 36,290.32. This was the ADR's fourth consecutive day of gains. AstraZeneca PLC ADR closed $5.81 below its 52-week high ($64.21), which the company reached on November 2nd.
The ADR outperformed some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.38% rose 0.23% to $137.29, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.87% fell 0.27% to $231.76, and Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.51% fell 0.17% to $72.25. Trading volume (3.5 M) remained 1.3 million below its 50-day average volume of 4.8 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
AZN
Add to watchlist
DJIA
Add to watchlist
ABBV
Add to watchlist
AMGN
Add to watchlist
GILD
